References
- VrankenJHMechanisms and treatment of neuropathic painCent Nerv Syst Agents Med Chem20099717820021340
- SiddallPJMcClellandJMRutkowskiSBCousinsMJA longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injuryPain200310324925712791431
- OsterbergABoivieJThuomasKACentral pain in multiple sclerosis – prevalence and clinical characteristicsEur J Pain2005953154216139182
- AndersenGVestergaardKIngeman-NielsenMJensenTSIncidence of central post-stroke painPain1995611871937659428
- TesellRWMehtaSAubutJASpinal Cord Injury Rehabilitation Evidence Research TeamA systematic review of pharmacologic treatments of pain after spinal cord injuryArch Phys Med Rehabil20109181683120434623
- SolaroCMessmer UccelliMPharmacological management of pain in patients with multiple sclerosisDrugs2010701245125420568832
- KlitHFinnerupNBJensenTSCentral post-stroke pain: clinical characteristics, pathophysiology, and managementLancet Neurol2009885786819679277
- Widerström-NogaEGFelipe-CuervoEYezierskiRPChronic pain after spinal injury: interference with sleep and daily activitiesArch Phys Med Rehabil2001821571157711689978
- SaverinoASolaroCPain in individuals with multiple sclerosis, knee prosthesis, and post-herpetic neuralgia: learning from focus group patients’ experienceClin J Pain20122830030822330129
- SiddallPJCousinsMJOtteAGriesingTChambersRMurphyTKPregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trialNeurology2006671792180017130411
- KimJSBashfordGMurphyTKMartinADrorVCheungRSafety and efficacy of pregabalin in patients with central post-stroke painPain20011521018102321316855
- CardenasDDNieshoffECSudaKA randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injuryNeurology20138055353923345635
- VrankenJHDijkgraafMGKruisMRvan der VegtMHHollmannNWHeesenMPregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimenPain200813615015717703885
- PolmanCHReingoldSCEdanGDiagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”Ann Neurol20055884084616283615
- KurtzkeJFRating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)Neurology198333144414526685237
- MelzackRThe short-form McGill Pain QuestionnairePain1987301911973670870
- DautRLCleelandCSFlaneryRCDevelopment of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseasesPain1983171972106646795
- RaichleKAOsborneTLJensenMPCardenasDThe reliability and validity of pain interference measures in persons with spinal cord injuryJ Pain2006717918616516823
- SatohJYagihashiSBabaMSuzukiMArakawaAYoshiyamaTEfficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trialJ Diabetes Investig20112457463
- OgawaSSuzukiMArakawaAYoshiyamaTSuzukiMLong-term efficacy and safety of pregabalin in patients with postherpetic neuralgia: results of a 52-week, open-label, flexible-dose studyMasui201059961970 Japanese20715519
- ParsonsBSaninLYangREmirBJuhnMEfficacy and safety of pregabalin in patients with spinal cord injury: a pooled analysisCurr Med Res Opin2013291675168323998397